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Abstract
Identification of potential viral-host protein interactions is a vital and useful approach towards development of new drugs
targeting those interactions. In recent days, computational tools are being utilized for predicting viral-host interactions.
Recently a database containing records of experimentally validated interactions between a set of HIV-1 proteins and a set of
human proteins has been published. The problem of predicting new interactions based on this database is usually posed as
a classification problem. However, posing the problem as a classification one suffers from the lack of biologically validated
negative interactions. Therefore it will be beneficial to use the existing database for predicting new viral-host interactions
without the need of negative samples. Motivated by this, in this article, the HIV-1–human protein interaction database has
been analyzed using association rule mining. The main objective is to identify a set of association rules both among the HIV-
1 proteins and among the human proteins, and use these rules for predicting new interactions. In this regard, a novel
association rule mining technique based on biclustering has been proposed for discovering frequent closed itemsets
followed by the association rules from the adjacency matrix of the HIV-1–human interaction network. Novel HIV-1–human
interactions have been predicted based on the discovered association rules and tested for biological significance. For
validation of the predicted new interactions, gene ontology-based and pathway-based studies have been performed. These
studies show that the human proteins which are predicted to interact with a particular viral protein share many common
biological activities. Moreover, literature survey has been used for validation purpose to identify some predicted interactions
that are already validated experimentally but not present in the database. Comparison with other prediction methods is also
discussed.
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Introduction
Interactions between proteins are important biochemical
reactions which determine different biological processes. Analysis
of the regulation between viral and host proteins in different
organisms is an important step to uncover the underlying
mechanism of various viral diseases. Human immunodeficiency
virus (HIV) is a lentivirus (a member of the retrovirus family with
long incubation period) that can lead to acquired immunodefi-
ciency syndrome (AIDS), a condition in humans in which the
immune system begins to fail, leading to life-threatening infections
[1]. HIV-1 is a species of the HIV virus that relies on human host
cell proteins in virtually every phase of its life cycle. One of the
main goals in research of Protein-Protein Interaction (PPI) is to
predict possible viral-host interactions. This is specifically aimed at
assisting drug developers targeting protein interactions for the
development of specially designed small molecules to inhibit
potential HIV-1–human PPIs. Targeting protein-protein interac-
tions has relatively recently been established to be a promising
alternative to the conventional approach to drug design [2,3].
There are several computational approaches for predicting
PPIs [4]. In [5], different data sources have been combined
using Bayes classifier for predicting PPIs in yeast. Different
classification methods have been compared in [6] and it has
been found that random forest classifier performs the best. In a
study by Yamanishi et al., new protein interactions have been
predicted using a variant of kernel canonical correlation analysis
[7]. In [8], a decision tree has been constructed to predict co-
complexed protein pairs by integration of genomic and
proteomic data. Afterwards, some kernel methods have also
been described for predicting novel PPIs [9]. An approach
called Mixture-of-Feature-Experts (mixture of classifiers) is
proposed in [10] to predict the set of interacting proteins in
yeast and human cells. In this approach the features are split
into roughly homogeneous sets of feature experts (classifiers).
Each of the individual experts uses logistic regression and finally
their scores are combined using another logistic regression.
Most of the above approaches are mainly used for determining
PPIs in a single organism, such as yeast, human etc. However,
determination of PPIs across multiple organisms such as between
viral proteins and the corresponding host proteins can contribute
to the development of new therapeutic approaches and design of
drugs for these viral diseases. There are some recent computa-
tional approaches in predicting and analyzing HIV-1-human PPIs.
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random forest classifier for predicting new HIV-1-human PPIs.
The authors extended their method by integrating a semi-
supervised approach for selecting positive interactions in [12].
Doolittle et al. recently proposed a structural similarity based
approach for predicting HIV-1–human protein interactions [13].
A support vector machine classifier based approach is presented in
[14]. In a recent study by MacPherson et al. [15], an analysis of
the HIV-1–human PPI network using a biclustering method has
been done to identify significant host-cellular subsystems. A similar
approach is adapted in [16] to find immunodeficiency gateway
proteins and their involvement in microRNA regulation. In [17], a
preliminary study on association rule mining based prediction of
HIV-human PPI has been reported.
The computational methods for predicting HIV-1–human PPIs
are mainly based on designing some classifiers which need both
positive and negative samples for PPIs. Although there are several
online resources that systematically store information about
experimentally validated interacting proteins, there is no such
resource for non-interacting proteins which should be used as the
ideal negative samples. Therefore in most of the works in this area,
negative samples are prepared by taking random protein pairs
which are not found in the interaction database. This is done with
the expectation that this random protein pairs are less likely to
interact physically, which may not be true always. The
performance of the classifier highly depends on the choice of the
negative samples.
With this observation, in this article we have proposed an
approach based on association rule mining (ARM) [18] that uses
information of positive samples of experimentally validated PPIs
only [19,20]. The PPI information among HIV-1 and human
proteins are organized as a binary matrix with rows representing
the human proteins and columns representing the HIV-1 proteins
or vice-versa. Thereafter, novel association rule mining technique
based on a biclustering method has been developed and the
proposed technique is used for discovering association rules among
the viral proteins as well as human proteins. Finally these rules
have been utilized to predict some new viral-host interactions and
their biological relevance has been studied.
Results and Discussion
In this section, the procedure for mining ARs from HIV-1–
human PPI network has been described. First we describe the
preparation of the input data set. Thereafter, how to apply the
proposed algorithm on the input data set to discover highly
confident rules and how these rules are used to predict new
interactions are discussed. Finally, the results of mining ARMs
from HIV-1-human PPI network are reported and discussed.
Preparation of the Input Data Set
The HIV-1–human PPI database [19] consists of total 2534
interactions between 19 HIV-1 proteins and 1432 human proteins.
We have constructed a binary matrix of human and viral proteins,
HV of size 1432|19 (File S1), and its transpose matrix VH of
size 19|1432 (File S2). An entry of 1 in the matrices denotes the
presence of interaction between the corresponding pair of human
and HIV-1 proteins, and an entry of 0 represents the absence of
any information regarding the interaction of the corresponding
human and viral proteins. Initially it is treated as non-interaction.
The resulting binary matrices is treated as the input to the BiMax
biclustering algorithm [21].
Finding ARs from the PPI Data Set
As discussed above, the rows of the input binary matrix HV
represent the human proteins and the columns represent the viral
proteins. Here each row (human protein) has been considered as a
transaction and each column (viral protein) has been considered as
an item. Therefore, in each transaction, the items, for which the
corresponding value in the matrix is 1, are considered to be
purchased by the transaction. This means, with a human protein,
some of the viral proteins (for which corresponding entry in the
row is 1) interact. Thereafter, the proposed ARM algorithm is
applied on these transactions to find highly confident ARs. As an
example, a discovered AR may be of the form:
fVP1VP2VP3[VP4g:
Here VPis, i~1,...,4, represent four HIV-1 proteins. In words,
the rule can be interpreted as follows: If the HIV-1 proteins VP1,
VP2 and VP3 interact with some human protein, the HIV-1
protein VP4 is also likely to interact with the same human protein.
Corresponding to each rule, there is an associated set of human
proteins for which the rule is true.
In a similar fashion, we also extract the ARs from the VH
matrix, where the viral proteins are in the rows and the human
proteins are in the columns. Hence from this matrix, the extracted
rules are of the following form:
fHP1HP2HP3[HP4g:
Here HPis, i~1,...,4, represent four human proteins. In this
case also, there is an associated set of viral proteins for each such
rule.
Filtering extracted ARs. Here we have used a two-step
filtering process to obtain high-confident, non-redundant and most
general ARs. The two steps are as follows:
Step-1: Removing Less-confident rules. In this step, the
rules that have confidence less than the provided min conf value
are removed.
Step-2: Removing redundant rules. For removing the
redundant rules, the following filtration is adopted: Consider a
rule R1 : X[Y. We say that the rule R1 is redundant if there
exists another rule R2 : Z[Y with same consequent, and Z5X
while both R1 and R2 have confidence greater than or equal to
min conf. In this case the rule R2 is said to be more general than
rule R1. We remove the rules that are redundant.
The two steps of the filtering process are applied one by one on
the initially extracted rules to obtain high-confident, non-
redundant and most general rules for further use.
Prediction of new interactions from ARs. We have
utilized the filtered ARs to predict new viral-host interactions as
follows: Consider again the rule fVP1VP2VP3[VP4g obtained
from the HV matrix. Suppose in the frequent itemsets, the
antecedent of the rule is true for 8 human proteins
fHP1,HP2,...,HP8g. Now without loss of generality, assume
that among these 8 human proteins, the consequent of the rule is
true for the first 6 human proteins fHP1,HP2,...,HP6g.
Therefore the rule has a confidence of 75% (6 out of 8), which
can be thought as reasonably high. From this we can predict that
the viral protein VP4 is also likely to interact with the human
proteins HP7 and HP8 and the confidence of this prediction is
75%. Thus two new interactions are predicted (HP7<VP4 and
HP8<VP4. The same procedure can be applied on the rules
obtained among the human proteins for the VH matrix to predict
some new interactions with certain confidence levels. This way,
Biclustering for Predicting HIV-1–Human PPI
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new interactions with certain levels of confidence from both HV
and VH matrices and the union of these sets of predicted
interactions is used as the final predicted set of interactions. Fig. 1
shows the flow chart of the procedure used in this article for
predicting new interactions.
The following text describes the experimental results. Note that
we have two binary matrices in hand: HV and VH. As there are
19 HIV-1 proteins and 1432 human proteins, the sizes of the HV
and VH matrices are 1432|19 and 19|1432, respectively.
These two matrices are processed separately and finally the
predicted interactions are merged to get the final predictions.
Results on HV Matrix
As the HIV-1 proteins are in the columns of HV matrix, we
obtain the rules among HIV-1 proteins from this. Since the PPI
data set is very sparse, the minimum support value should be low
enough to obtain sufficient number of frequent closed itemsets.
After several experiments, the min sup value is set to 20 (,1.4%)
and the min conf value is set to 70%.
By applying the BiMax algorithm with the specified parameters
discussed above, we extracted 48 all-1 maximal biclusters, i.e., 48
frequent closed itemsets. From these frequent closed itemsets, 123
unique rules with single consequent are generated. Thereafter, we
apply the filters on the extracted rules. After applying the Step-1
Figure 1. Flowchart of the process of predicting new interactions.
doi:10.1371/journal.pone.0032289.g001
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26 and 15, respectively. Fig. 2 shows the final set of 15 rules among
the viral proteins.
Subsequently we apply the proposed method to predict new
interactions. When the rules shown in Fig. 2 are applied on the
HV matrix, it generates a total of unique 140 new predicted
interactions with different confidence levels. As can be seen from
the Fig. 2, there are 4 different HIV-1 proteins (env_gp120 (5
rules), integrase (1 rule), Tat (8 rules) and Vif (1 rule)) in the
consequent parts of the rules, hence all the predicted interactions
involve only these HIV-1 proteins. The number of unique human
proteins involved in these interactions is 130.
Results on VH Matrix
For the VH matrix, there are large number of items (1432
human proteins) in the columns of the matrix, whereas the
number of rows of the matrix is only 19 (corresponding to 19 viral
proteins). Hence, in this case the minimum support value can be
much larger than that in case of HV matrix. Experimentally, we
set the min sup value to 5 (,26.32%) and the min conf value to
70%.
Application of BiMax algorithm with the above parameters
yields 74 all-1 maximal biclusters, which is equivalent to 74
frequent closed itemsets. Thereafter we extracted 361 unique rules
with single consequent from these frequent closed itemsets.
Subsequently, the extracted rules are filtered and the Step-1 and
Step-2 of the filtration process minimize the number of rules to 50
and 36, respectively. In Fig. 3, we have shown the final set of 36
rules among the human proteins.
Next, the proposed method is applied to predict new
interactions. The rules shown in Fig. 3 in turn predict 43 new
interactions from the VH matrix. As is evident from Fig. 3, there
are 16 different human proteins (ACTB (2 rules), ACTG1 (6 rules),
BCL2 (1 rule), BCL2L1 (1 rule), CASP3 (3 rules), CCL3 (1 rule),
CD4 (3 rules), CYCS (1 rules), HSPA5 (1 rule), IFNG (5 rules),
IL10 (1 rule), MAPK1 (4 rules), MAPK3 (1 rule), NFKB1 (1 rule),
NFKBIA (2 rules), PRKCA(3 rules)) in the consequent parts of the
rules. Therefore all the predicted interactions from VH matrix
involve these human proteins. On the other hand, the number of
unique HIV-1 proteins in these interactions is 15 (capsid,
env_gp120, env_gp160, env_gp41, Gag_Pr55, matrix, Nef,
nucleocapsid, p6, retropepsin, Rev, RT, Vif, Vpr, Vpr).
Predicted Interactions
The predicted interactions from HV matrix (140 interactions)
and VH matrix (43 interactions) are merged together by taking
union. Only three interactions have been found to be common in
both the sets (env_gp120<ACTB, env_gp120<ACTG1 and
env_gp120<BCL2L1). Hence it is evident that the predictions
from HV and VH matrices are mostly different from each other.
This indicates that both forms of the adjacency matrix are equally
important in predicting new interactions. Taking the union of the
two predicted sets, the final set of predictions containing 180
unique interactions are formed. We studied the distribution of the
confidence levels of the interactions. In this regard, Fig. 4 shows
the histogram of the distribution of the number of predicted
interactions at different confidence level. It can noted from the
figure that at confidence level 78%–80%, there are the maximum
number (40) of predicted interactions. There are also many
interactions with high confidence value (w80%).
This final set of 180 predicted interactions involves 17 unique
HIV-1 proteins (capsid, env_gp120, env_gp160, env_gp41, Tat,
integrase, Gag_Pr55, matrix, Nef, nucleocapsid, p6, retropepsin,
Rev, RT, Vif, Vpr, Vpu) and 140 human proteins. It is stated in
[20] that some HIV-1 proteins interact with multiple proteins
belonging to specific protein complex or cellular pathway, which
represent specific cellular activities. Conversely, 37% of the host
proteins in the database interacts with more than one HIV-1
protein. In the predicted set, we found that some HIV-1 proteins
interact with multiple human proteins and biological relevance
study based on gene ontology reveals that the human proteins
interacting with a single viral protein share common biological
activities and participate in common cellular pathways. Moreover,
it is also observed that in the predicted interactions, many human
proteins (14.29%) interact with more than one HIV-1 proteins
similar to the observation reported in [20].
For the purpose of illustration, the predicted bipartite network
has been shown in Fig. 5. It appears from the figure that there are
Figure 2. Final Set of 15 Association Rules among HIV-1 Proteins Generated from HV Matrix.
doi:10.1371/journal.pone.0032289.g002
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Figure 4. Distribution of the number of predicted interactions at different confidence levels.
doi:10.1371/journal.pone.0032289.g004
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with 64 (35.56%) and 59 (32.78%) human proteins, respectively.
Interestingly, in the original interaction database it is found that
env_gp120 and Tat interact with 33% and 30% host proteins [20].
Hence these percentages are very near to those in the predicted
interaction data set. The HIV-1 protein env_gp120 is embedded
in the HIV envelop which helps the virus to attach to and fuse with
the target cell, whereas Tat mainly plays the role of increasing the
rate of transcription in the host cell. So both of them play
important role in viral life cycle and are expected to interact with
many proteins in the host cell for possible infection. The next
HIV-1 hub protein in the predicted network is Vif, which is
predicted to interact with 15 human proteins. Vif protein is known
to be responsible for disruption of antiviral activities of human cells
and expectedly interacts with many human proteins for this
purpose. The degrees of other viral proteins in the predicted
network are as follows: capsid - 3, env_gp160 - 5, env_gp41 - 4,
integrase - 6, Gag_Pr55 - 3, matrix - 2, Nef - 2, nucleocapsid - 3,
p6 - 2, retropepsin - 2, Rev - 3, RT - 2, Vpr - 3, and Vpu - 2.
Interestingly, Nef is predicted to interact with two human proteins
CYCS and HSPA5, with which, no the viral protein is found to
interact in the predicted set. The complete set of predicted
interactions is given in the additional File S3 along with the
predictions from both HV and VH matrices separately.
Biological Relevance of Predicted Interactions
In this section, we examine the properties of human proteins
that interact with each HIV-1 proteins based on gene ontology
based study. The results of these experiments are reported below.
Interactions with env_gp120. As stated above, 64 human
proteins have been predicted to interact with the viral protein
env_gp120. Here we attempt to study the biological relationships
among these 64 human proteins. First, we conducted a gene
ontology (GO) based study to find whether there are any
significant GO terms in the three categories of GO using
DAVID functional annotation tool (http://david.abcc.ncifcrf.
gov). To obtain the significant non-redundant GO terms, we
have utilized a recently developed web server REVIGO (http://
revigo.irb.hr/) [22] which takes as input a list of GO terms along
with p-values and a GO-based semantic similarity measure, and
outputs the set of non-redundant terms along with Dispensability
values for each term. Lower value of Dispensability indicates lesser
redundancy of the corresponding term [22]. We have used the
default parameter setting of REVIGO as provided in the web
server. Tables 1, 2 and 3 show the significant and non-redundant
GO terms for certain thresholds of p-value and dispensability (as
shown in the respective captions) under Biological Process,
Cellular Component and Molecular Function Categories, respec-
tively. It is evident from the tables that the group of human
proteins that are predicted to interact with env_gp120 are
biologically related and possess common biological activities. It is
interesting to note from Table 1 that 21.67% of these human
proteins are involved in biological process membrane organization.
Also Table 2 shows that many of these proteins are component of
coated membrane (20%). This is an important observation because as
stated earlier env_gp120 is embedded in the HIV envelop which
helps the virus to attach to and fuse with the target cell. In this
process it needs to interact with many membrane proteins and our
predicted human proteins seem to be largely related with
membrane activities, and there is high chance that env_gp120
interacts with these proteins. From Table 1, it can also be found
that some of these human proteins are involved in the biological
process of death (18.33%) and regulation of defense response to virus by
virus (8.33%), which are important for promoting antiviral immune
response mechanism and thereby limiting viral replication. When
env_gp120 possibly interacts with these human proteins they affect
their activities and as a result the immune response system may
fail. This indicates that interaction of env_gp120 with these human
proteins may lead to cell death.
Interactions with Tat. Tat has the second most highest
degree (59) in the predicted interactions, and thus needs special
attention. For Tat also we have conducted similar GO study and
the results are shown in Tables 4, 5, and 6. It is evident that in this
case also, the human proteins have many significant terms in each
Figure 5. The predicted bipartite network involving 17 HIV-1 proteins and 140 human proteins. HIV-1 proteins are represented by large
red circles and human proteins are represented by small blue circles. The interactions predicted from VH matrix are represented by black lines and
the interactions predicted from HV matrix are represented by green lines. Line widths are proportional to the confidence of the predictions.
doi:10.1371/journal.pone.0032289.g005
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sufficiently different from that in the case of env_gp120. It appears
from Table 4 that many of these human proteins are involved in
defense response, positive regulation of apoptosis and response to virus. These
are vital observations since Tat is known to vastly increase the level
of transcription of HIV dsRNA, thus allowing HIV an explosive
response once certain amount of Tat is produced. This endangers
the immune activities inside the cell. Therefore it is expected that
Tat interacts with the human proteins that are involved in immune
and defense activities to make them inactive. Moreover Tat has
been found to act as toxin producing cell death via apoptosis in
uninfected T cells, which assists in progression towards AIDS.
Furthermore, it appears from Table 6 that 9.09% proteins are
associated with the molecular function protein transporter activity,
which means these proteins may be highly involved in transporting
infection signal to different parts of a cell or between cells. Hence
the predicted human proteins interacting with Tat are quite
intuitive since they share many biological properties related to
HIV infection and progression.
Interactions with Vif. The other less-dense HIV-1 hub
protein found in the predicted interactions is Vif, the virion
infectivity factor. This protein is known to interfere with the
immune system’s defences and increases the infectivity of the HIV
particle. The 15 human proteins that are predicted to be
interacting partners of Vif are found to share many common
significant GO terms as depicted in Tables 7, 8, and 9. The
proteins are mainly involved in nuclear and protein import
activities. Also, a large number of proteins (more than 50%) are
found to be involved in regulation of apoptosis. This indicates that
these human proteins may also be in the viral infection pathway
leading to cell death through apoptosis. Interestingly, we found
that out of these 15 human proteins, 5 of them are involved in
pathways in cancer (KEGG: hsa05200) suggesting that possible
viral infection may lead to some type of cancer.
Interactions with other HIV-1 proteins. The other HIV-1
proteins have smaller degrees in the predicted network. We also
studied the relationships among the human proteins that are
predicted to interact with some common HIV-1 protein through
GO and KEGG pathway enrichment test using DAVID. The
HIV-1 protein capsid interacts with ACTG1, MAPK1 and
PRKCA. Interestingly, these three proteins interact with each
other as found in the STRING database (http://string-db.org).
Another envelop protein env_gp160 is predicted to interact with 5
human partners ACTB, ACTG1, CASP3, CCL3, and IL10.
These five partners have significant involvement in cell motion,
regulation of B-cell activation/proliferation, and regulation of T-cell
activation/proliferation. Thus these proteins are involved in humoral
and cell-mediated immune response and viral infection affects
these immune activities. The env_gp141 is predicted to interact
with BCL2, MAPK1, NFKB1 and NFKBIA, which are found to
be significantly involved in the B-cell/T-cell signaling pathway,
apoptosis and programmed cell death. Moreover all of them are
involved in the signaling pathway of prostate cancer. This is interesting
since it suggests that HIV-1 infection through env_gp41 may
indirectly cause prostate cancer. The Gag_Pr55 is predicted to
interact with CD4, IFNG, MAPK1 and all these three proteins
take part in the positive regulation of immune system process. The proteins
are also found in the T-cell receptor signaling pathway. Thus they are
responsible for the immunity of the host. The human proteins
CD4, IFNA1, MAPK1, MAPK3, SAT1, and TCEB2 are
predicted to interact with integrase. Out of these six human
proteins three (MAPK1, MAPK3 and TCEB2) are found to be in
the T-cell receptor signaling pathway and the pathway leading to renal
cell carcinoma. The human proteins IL10, NFKBIA are predicted to
interact with the viral protein matrix. Both of these human
proteins actively participate in maintenance of protein locations in cell
and regulation of transcription factor activity. The viral protein Nef is
predicted to interact with CYCS and HSPA5. Expression of Nef
Table 1. Significant non-redundant GO terms (p-valuev1E-03, Dispensabilityv0.05) under Biological Process category found in
the human proteins that are predicted to interact with HIV-1 protein env_gp120.
Sl. No. GO-id Term p-value % of Proteins Dispensability
1 GO:0007568 aging 8.91E-05 10.00 0.00
2 GO:0016192 vesicle-mediated transport 8.11E-10 28.33 0.00
3 GO:0016265 death 6.87E-04 18.33 0.00
4 GO:0050690 regulation of defense response to virus by virus 1.82E-08 8.33 0.00
5 GO:0030029 actin filament-based process 4.63E-04 11.67 0.04
6 GO:0016044 membrane organization 3.82E-08 21.67 0.04
7 GO:0006928 cell motion 7.03E-04 15.00 0.04
doi:10.1371/journal.pone.0032289.t001
Table 2. Significant non-redundant GO terms (p-valuev1E-08, Dispensabilityv0.05) under Cellular Component category found in
the human proteins that are predicted to interact with HIV-1 protein env_gp120.
Sl. No. GO-id Term p-value % of Proteins Dispensability
1 GO:0030131 clathrin adaptor complex 1.61E-19 20.00 0.00
2 GO:0031982 vesicle 3.54E-11 33.33 0.00
3 GO:0012505 endomembrane system 3.83E-09 31.67 0.00
4 GO:0048475 coated membrane 2.54E-15 20.00 0.04
doi:10.1371/journal.pone.0032289.t002
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infected cells by downmodulating the expression of several surface
molecules important in host immune function. Interestingly, these
two human proteins have involvement in apoptosis and programmed
cell death. The HIV-1 protein nucleocapsid is found to interact with
CASP3, IFNG and PRKCA, and importantly, these three human
proteins are significantly involved in negative regulation of cell
proliferation, positive regulation of apoptosis and programmed cell death.
Moreover they are involved in the KEGG pathway of natural killer
cell mediated cytotoxicity (hsa04650). The human proteins predicted to
interact with the HIV-1 proteins p6, retropepsin, Rev, RT, Vpr
and Vpu also share many biological activities related to immune
response, apoptosis and programmed cell death.
Evidences from Recent Literature
To establish that the predicted interactions have potentials to
exist in reality, we have extensively searched PUBMED to find
recent reports on interactions between HIV-1 and human proteins
which are not included in the interaction database considered
here. We have found some of the predicted interactions which are
experimentally validated and reported in recent literature. For
example, we have predicted the interaction between env_gp120
and CASP8 with confidence 83.33% (File S3). In [23] it has been
found that env_gp120 expression induces CASP8 activation and
apoptosis. Also our prediction between env_gp120 and CD86
(confidence 83.33%) has been supported in [24], which found that
env_gp120 infection causes upregulation of CD86. The human
protein NOS3 is also predicted to interact with env_gp120 with
confidence level 74.67% by our method. It has been shown in [25]
that env_gp120 and TNF-alpha synergistically reduce NOS3
expression in both mRNA and protein level. Two other human
proteins, SOD2 and SRC are predicted to interact with
env_gp120 with confidence levels 88.89% and 78%, respectively.
These interactions are also supported by the works in [26] and
[27], respectively. Differential regulation of SOD2 in neurons and
astroglia is affected by env_gp120 [26]. It is reported in [27] that
soluble env_gp120 activates multiple protein kinases in primary
human monocyte-derived macrophages, including the SRC family
kinase. In [28], it is established that env_gp41 peptide 6358
activates the CD74-mediated ERK/MAPK pathway and signif-
icantly enhanced HIV-1 infection. It is interesting that our
prediction includes the interaction between env_gp41 and
MAPK1 with confidence level 77.78%. We have also predicted
interaction of MAPK1 with the viral protein Gag_Pr55 with
71.43% confidence. In [29], the authors have shown that MAPK/
ERK-2 interacts with the poly-proline motif present in the capsid
region of Gag_Pr55. In [30], it is reported that HIV-1 Tat protein
enhances RANKL (TNFSF)-mediated osteoclast differentiation.
We have predicted the interaction of Tat with TNFSF with
confidence level 86.30%. These evidences establish that many of
our predicted interactions, which are not in the HIV-1–human
interaction database, have already been reported and exist in
reality. This demonstrates the utility of the proposed method.
Overlaps with Existing Predictions
We have compared our predictions with that of Tastan et al.
[11] and Doolittle et al. [13]. Tastan et al. used a random forest
classifier based technique and predicted 3372 interactions. Each
prediction has an associated interaction score. Out of these, 2084
interactions are predicted to be novel interactions (not in the
database). The interaction scores of these interactions vary from 0
to 4.11 with a mean value of 0.5284. In [13], a structural similarity
based method have been proposed for predicting protein
interactions between HIV-1 and human and a total of 884 unique
interactions are predicted. Fig. 6 gives the Venn diagram showing
the overlaps among the three prediction studies. It is evident that
the predictions from these three methods have reasonably low
overlaps. This is not quite unexpected because even large-scale
experimental protein interaction studies do not typically show high
degree of overlaps among them. Moreover, these three prediction
Table 3. Significant non-redundant GO terms (p-valuev1E-02, Dispensabilityv0.05) under Molecular Function category found in
the human proteins that are predicted to interact with HIV-1 protein env_gp120.
Sl. No. GO-id Term p-value % of Proteins Dispensability
1 GO:0008565 protein transporter activity 7.43E-08 13.33 0.00
2 GO:0008454 alpha-1,3-mannosylglycoprotein 4-beta-N-
acetylglucosaminyltransferase activity
5.27E-05 5.00 0.00
3 GO:0042802 identical protein binding 1.35E-03 16.67 0.00
doi:10.1371/journal.pone.0032289.t003
Table 4. Significant non-redundant GO terms (p-valuev1E-03, Dispensabilityv0.15) under Biological Process category found in
the human proteins that are predicted to interact with HIV-1 protein Tat.
Sl. No. GO-id Term p-value % of Proteins Dispensability
1 GO:0006897 endocytosis 2.23E-05 14.55 0.00
2 GO:0006952 defense response 6.46E-08 27.27 0.00
3 GO:0070661 leukocyte proliferation 6.71E-04 7.27 0.00
5 GO:0001775 cell activation 1.20E-04 14.55 0.03
6 GO:0043065 positive regulation of
apoptosis
2.47E-04 16.36 0.03
7 GO:0009615 response to virus 8.62E-04 9.09 0.10
doi:10.1371/journal.pone.0032289.t004
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different number of interactions. From Fig. 6 it can be noticed
that the predictions from the present study have overlap of 80
interactions with that of Tastan et al., whereas the number of
overlaps between our method and Doolittle’s method is only 5. We
have reported the common predictions between the studies in this
paper and Tastan et al. in File S4. These 80 common predictions
may be closely observed and are interesting candidates for
further studies. Note that among these common interactions,
4 interactions (env_gp120<CASP8, env_gp120<SRC, en-
v_gp41<MAPK1, and Gag_Pr55<MAPK1) are already estab-
lish by experimental validation as discussed in the previous section.
The 5 common interactions between our study and that of
Doolittle et al. are capsid<MAPK1, env_gp41<NFKB1, en-
v_gp41<MAPK1, integrase<CD4, and integrase<MAPK1.
There are 4 interactions which are predicted by all three methods.
These interactions are capsid<MAPK1, env_gp41<MAPK1,
integrase<CD4, and integrase<MAPK1. As these 4 interactions
are common to all methods, these might be important candidates
for further investigations. Among these, as discussed in the
previous section, env_gp41<MAPK1 already has evidence in
literature [28]. In summary we can say that little overlaps among
the predicted interactions from different methods suggest that
these methods might be complementary to each other for
identifying novel interactions between HIV-1 and human proteins.
Summary and Discussion
In this article we have posed the problem of predicting new
HIV-1–human protein interactions based on the existing PPI
database as an association rule mining problem. This is motivated
by the difficulty in posing the problem as a classification one due to
lack of proper negative PPI samples. In this regard, a novel
association rule mining approach based on BiMax biclustering
method has been proposed. The proposed technique has been
used to mine the frequent closed itemsets from the HIV-1–human
PPI database organized as a binary matrix. The non-redundant
association rules of high confidence have been generated and a
novel method for predicting new interactions from the generated
rules has been proposed. The proposed method has been shown to
predict new viral-host interactions with certain confidence levels.
For validation of the predicted new interactions, gene ontology-
based and pathway-based study have been performed. Ptak et al.
[20] noticed that some HIV-1 proteins interact with multiple
proteins belonging to specific protein complex or cellular pathway,
which represent specific cellular activities. Similar trend is noticed
for the predicted interactions as well. The GO and pathway
studies reveal that the human proteins that are predicted to
interact with a particular viral protein share many common
biological activities that are mainly related to immune response,
apoptosis and programmed cell death. Moreover, in some of the
cases, we found that the group of human proteins interacting with
a viral protein are involved in the pathway of some type of cancer
suggesting that HIV-1 infection may lead to several types of cancer
through its infection pathway. Moreover, we have shown some
evidences from recent literature which demonstrate that some of
our predicted interactions are already established through
experimental validation. Finally we have discussed the overlaps
of our predicted interactions with that by two other existing
methods for HIV-1–human PPI prediction.
One possible criticism of the proposed technique might be that
it can only predict new interactions involving the human proteins
present in the HIV-1–human database. However, if some viral
protein is predicted to interact with a human protein, the human
proteins that are structurally similar to the target human protein or
that have same domains as in the target human protein, are also
likely to interact with the concerned viral protein [13]. Hence it is
evident that although our method does not directly predict
interactions involving human proteins not present in the
interaction database, it can predict the possibility of interactions
of HIV-1 proteins with new cellular factors that are structurally
similar with the human proteins involved in predicted interactions.
In this work, we have used a simple model that does not
differentiate among the different types of interactions present in
the interaction database. The main interest of this study is to
Table 5. Significant non-redundant GO terms (p-valuev1E-02, Dispensabilityv0.15) under Cellular Component category found in
the human proteins that are predicted to interact with HIV-1 protein Tat.
Sl. No. GO-id Term p-value % of Proteins Dispensability
1 GO:0005829 cytosol 2.30E-10 43.64 0.00
2 GO:0031982 vesicle 5.27E-05 21.82 0.00
3 GO:0048475 coated membrane 1.13E-04 9.09 0.00
4 GO:0031226 intrinsic to plasma
membrane
2.47E-03 23.64 0.06
doi:10.1371/journal.pone.0032289.t005
Table 6. Significant non-redundant GO terms (p-valuev1E-02, Dispensabilityv0.15) under Molecular Function category found in
the human proteins that are predicted to interact with HIV-1 protein Tat.
Sl. No. GO-id Term p-value % of Proteins Dispensability
1 GO:0008565 protein transporter activity 3.17E-04 9.09 0.00
2 GO:0016814 hydrolase activity, acting on carbon-nitrogen
(but not peptide) bonds, in cyclic amidines
6.05E-03 5.45 0.00
3 GO:0051219 phosphoprotein binding 1.39E-04 7.27 0.00
doi:10.1371/journal.pone.0032289.t006
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association rules and using the derived rules to predict new
interactions. Hence it is not straightforward to annotate the
predicted interactions. Although GO-based study gives us some
insights into the sub-cellular locations of predicted interactions
(GO cellular components), a more detailed study is needed and
initial assumptions are to be revised for more clear overview of the
viral replication process. Our future plan is to consider all possible
types of interactions present in the database initially to build the
interaction matrix (matrix will no longer be a binary one), and also
to consider the directions of interactions (virus-to-host, host-to-
virus or undirected). Starting with this, the derived rules will then
be able to predict the annotated interactions along with their
directions. This is expected to more clearly explain the process of
HIV-1 replications by predicting interactions in different stages of
viral life cycle with possible sub-cellular compartments where the
interactions are taking place. The authors are now working in
these directions.
Materials and Methods
HIV-1–Human PPI Data Set
The interaction information reported between HIV-1 and
human proteins has been prepared based on a recently published
PPI interaction data set [19] (http://www.ncbi.nlm.nih.gov/
RefSeq/HIVInteractions/). The database was accessed in March
2011 to prepare the PPI data set for the present study. There are
total 2534 interactions between 19 HIV-1 proteins and 1432
human proteins. The interaction information in the database is
derived from small scale protein interactions curated from
published materials. The PPIs reported in the database are
specifically annotated according to the nature of the interactions
including over 68 interaction types such as ‘‘binds to’’, ‘‘interacts
with’’, ‘‘upregulates’’ and ‘‘phosphorylates’’. The types of
interactions can be broadly classified into direct physical
interactions (e.g., ‘‘binds to’’), that comprise of 32% of the
interactions and indirect interactions (e.g., ‘‘upregulates’’) that
comprise of 68% of the interactions. Both direct and indirect
interactions are considered in our study since indirect interactions
also contain valuable information about the characteristics of the
interacting proteins. Including the information, at the beginning of
the analysis is expected to be beneficial for predicting novel
interactions, both direct as well as indirect. Moreover, the natures
of interactions are also not considered separately. We have
constructed a binary matrix of human and viral proteins, HV of
size 1432|19, and its transpose matrix VH of size 19|1432.A n
entry of 1 in the matrices denotes the presence of interaction
between the corresponding pair of human and HIV-1 proteins,
and an entry of 0 represents the absence of any information
regarding the interaction of the corresponding human and viral
proteins. Initially it is treated as non-interaction.
Association Rule Mining
The principle of association rule mining (ARM) lies in the
market basket or transaction data analysis. Much information is
hidden in the day to day transactions taking place in supermarkets.
For example a customer who is buying nappy also likes to
purchase baby food in the same time. Association analysis is the
discovery of rules showing attribute–value associations that occur
frequently [31]. Let I~fi1,i2,...,ing be a set of n items and Xmi
be an itemset where X5I.Ak-itemset is a set of k items. Let
T~f(t1,X1),(t2,X2),...,(tm,Xm)g be a set of m transactions,
where ti and Xi, i~1,2,...,m, are the transaction identifier and
the associated itemset respectively. The cover of an itemset X in T
is defined as follows:
cover(X,T)~ftij(ti,Xi)[T,X5Xig: ð1Þ
The support of an itemset X in T is
support(X,T)~jcover(X,T)jð 2Þ
and the frequency of an itemset is
Table 7. Significant non-redundant GO terms (p-value ,1E-04, Dispensability ,0.15) under Biological Process category found in
the human proteins that are predicted to interact with HIV-1 protein Vif.
Sl. No. GO-id Term p-value % of Proteins Dispensability
1 GO:0000060 protein import into nucleus,
translocation
2.34E-08 35.00 0.00
2 GO:0006259 DNA metabolic process 3.65E-06 50.00 0.03
3 GO:0033554 cellular response to stress 6.97E-06 50.00 0.04
4 GO:0042981 regulation of apoptosis 5.17E-05 50.00 0.04
doi:10.1371/journal.pone.0032289.t007
Table 8. Significant non-redundant GO terms (p-valuev1E-02, Dispensabilityv0.15) under Cellular Component category found in
the human proteins that are predicted to interact with HIV-1 protein Vif.
Sl. No. GO-id Term p-value % of Proteins Dispensability
1 GO:0005654 nucleoplasm 8.64E-06 57.14 0.00
2 GO:0031974 membrane-enclosed lumen 1.03E-03 57.14 0.00
3 GO:0005829 cytosol 7.62E-03 42.86 0.12
doi:10.1371/journal.pone.0032289.t008
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support(X,T)
jTj
: ð3Þ
Thus support of an itemset X is the number of transactions where
all the items in X appear in each transaction. The frequency of an
itemset is the probability of its occurrence in a transaction in T. An
itemset is called frequent if its support in T is greater than some
threshold min sup: The collection of frequent itemsets with respect
to a minimum support min sup in T, denoted by F(T,min sup) is
defined as
F(T,min sup)~fX5I,support(X,T)wmin supg: ð4Þ
The objective of ARM is to find all rules of the form X[Y,
X\Y~1 with probability c%, indicating that if itemset X
occurs in a transaction, the itemset Y also occurs with probability
c%. X and Y are called the antecedent and consequent of the rule
respectively. Support of a rule denotes the percentage of
transactions in T that contains both X and Y. This is taken to
be the probability P(X|Y). An association rule (AR) is called
frequent if its support exceeds a minimum value min sup:
The confidence of a rule X[Y in T denotes the percentage of
the transactions in T containing X that also contains Y: It is taken
to be the conditional probability P(XjY): In other words,
confidence(X[Y,T)~
support(X|Y,T)
support(X,T)
: ð5Þ
A rule is called confident if its confidence value exceeds a threshold
min conf. Formally the ARM problem can be defined as follows:
Find the set of all rules R of the form X[Y such that
R~fX[YjX,Y5I,X\Y~1,
X|Y(F(T,min sup),
confidence(X[Y,T)wmin confg: ð6Þ
Generally the ARM process consists of the following two steps
[32,33]:
1. Find all frequent itemsets.
2. Generate strong ARs from the frequent itemsets.
The number of itemsets grows exponentially with the number of
items jIj. A commonly used algorithm for generating frequent
itemsets is the Apriori algorithm [18,34]. This is based on the
concept of downward closure property which states that if even
one subset of an itemset X is not frequent, then X cannot be
frequent. It starts from all itemsets of size one, and proceeds in a
recursive fashion. If any itemset X is not frequent then that branch
of the tree is pruned, since any possible superset of X can never be
frequent.
Although Apriori is a popular algorithm, its computational
complexity becomes intractable for very low value of min sup and
when the number of items is very large. It is because low min sup
value generates very large number of frequent itemsets and
generation of such a large number of frequent itemsets takes huge
time. Moreover, it is necessary to ignore the redundant
information in the frequent itemsets. In this context, the concept
of closed itemsets [35,36] is important. An itemset is called closed
itemset if none of its proper supersets have the same support value.
It is beneficial to search for the closed itemsets in order to avoid
any redundancy. Moreover, frequent closed itemsets are con-
densed representation of frequent itemsets without loss of any
information. There is no provision in Apriori or similar algorithms
to directly search for the closed itemsets. In this article, we have
proposed a novel approach that utilizes a biclustering method [37]
for identifying the frequent closed itemsets directly.
Table 9. Significant non-redundant GO terms (p-value ,1.5E-02, Dispensability ,0.15) under Molecular Function category found
in the human proteins that are predicted to interact with HIV-1 protein Vif.
Sl. No. GO-id Term p-value % of Proteins Dispensability
1 GO:0008139 nuclear localization sequence
binding
1.94E-05 21.42 0.00
2 GO:0008134 transcription factor binding 1.30E-02 28.57 0.02
doi:10.1371/journal.pone.0032289.t009
Figure 6. Venn diagram showing the overlaps of predicted
interactions provided by the proposed method, by Tastan
et al. and by Doolittle et al.
doi:10.1371/journal.pone.0032289.g006
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2534 interacting pairs among 27208 possible protein pairs:
9.31%). Therefore it is required to use low min sup value for
generating frequent itemsets. Moreover when the PPI matrix is
arranged in a form in which the human proteins are considered as
the items, the computational time required to execute the Apriori
method is huge since the number of human proteins is 1432 in the
data set considered here. This is because the number of possible
itemsets to explore is in the order of 21432: Furthermore, it is also
important to find the frequent closed itemsets only to avoid
redundant information. Therefore, it is difficult to use Apriori
algorithm for this data set. Hence, we have proposed a new
association rule mining approach based on a biclustering method
that efficiently mines the frequent closed itemsets from sparse data
sets having low min sup value and large number of items. The
following section describes the proposed technique.
Association Rule Mining based on Biclustering
In this section, we first introduce the concept of biclustering and
thereafter, the proposed rule mining technique is described.
Biclustering. Biclustering technique, usually used in
microarray gene expression data, aims to identify a subset of
genes that are similarly expressed in a subset of experimental
conditions [37,38,39]. Given a g|c microarray data matrix
A(G,C) consisting of a set of g genes G~fI1,I2,...,Igg and a set
of c conditions C~fJ1,J2,...,Jcg, a bicluster can be defined as a
submatrix M(I,J)~½mij , i[I,j[J, of matrix A(G,C), where
I(G and J(C, and the subset of genes in the bicluster are
similarly expressed over the subset of conditions and vice versa.
Biclustering algorithms have been mainly developed to overcome
the shortcoming of standard clustering algorithms that fail to
detect similarity of genes over a subset of experimental conditions
[40,41,42].
Although biclustering algorithms are in general applied for
microarray gene expression data sets, they can be used in any data
matrix to discover submatrices with similar values. There are
different kinds of biclusters available, viz., constant, row-constant,
column-constant, additive pattern, multiplicative pattern, and
combination of both additive and multiplicative patterns [37].
Constant biclusters are of special interest where all the elements of
the biclusters have the same value. In case of a binary data set
where all values are either 0 or 1, a constant bicluster can be
thought as a submatrix, all the elements of which have value 1,
while 0 is considered as the background value. Thus for binary
data sets, identifying constant biclusters is equivalent to identifying
all-1 submatrices from the data set.
ARM from All-1 Biclusters. Suppose a transaction data set
is given that contains m transactions and n items. The data set can
be represented as a binary matrix with rows representing
transactions and columns representing items. If an element
tij~1, it implies that the item j is purchased in transaction i,
and if tij~0, then the transaction i does not purchase the item i:
Given this binary matrix, if we can find an all-1 bicluster that has
at least min sup number of rows (transactions), then the set of
columns (items) of that bicluster can be considered as a frequent
itemset. Hence each all-1 bicluster that satisfies the min sup
condition will provide a frequent itemset. Thus finding the set of
frequent itemsets is equivalent to find a set of all-1 biclusters each
having at least min sup number of rows.
Among the various biclustering techniques available in
literature, we have used Binary inclusion-Maximal (BiMax)
biclustering algorithm [21] that identifies all biclusters in the
input binary matrix. Based on this binary matrix, BiMax identifies
all maximal biclusters where a bicluster is defined as a submatrix E
containing all 1s. An inclusion-maximal bicluster means that this
bicluster is not completely contained in any other bicluster. Note
that the columns of a maximal bicluster constitute a closed itemset.
Hence the set of all-1 biclusters that satisfies the min sup condition
actually provides the set of frequent closed itemsets.
BiMax uses an incremental algorithm to find the inclusion-
maximal biclusters exploiting the fact that the matrix E induces a
biclique. An advantage of BiMax is that it does not need a priori
specification of the number of biclusters to be found.
Therefore, to find the possible association rules, we use the
following steps:
1. Given a min sup and a binary transaction matrix, apply BiMax
algorithm with parameters minimum number of rows=min sup
and minimum number of columns=2 to find all frequent closed
itemsets.
2. From each frequent closed k-itemset, k rules are generated by
moving one of the items at a time to the consequent part while
keeping the remaining items in the antecedent part of the rule.
Note that for generating the frequent closed itemsets, we ignore
the 1-itemsets as they can not produce any association rule. This is
done by fixing the minimum number of columns of the biclusters
to 2. Moreover, we consider only the rules having single
consequent to avoid redundant information, as our primary
objective is to predict new PPIs.
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